Comparison of the effect of two drugs on reducing bilirubin levels in neonates with jaundice

Comparison of the effect of clofibrate and zinc sulfate in reducing jaundice

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210922052558N1

Enrollment

250

Registered

2022-02-11

Start date

2022-04-04

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal jaundice. Neonatal jaundice due to other excessive hemolysis

Interventions

Intervention 1: Intervention group: In the clofibrate group, simple phototherapy is used with 100 mg per kilogram of body weight per day of oral clofibrate. Intervention 2: Intervention group: In the

Eligibility

Sex/Gender

All

Age

1 Days to 28 Days

Inclusion criteria

Inclusion criteria: Age 1 to 28 days Term and preterm infants With neonatal jaundice

Exclusion criteria

Exclusion criteria: Electrolyte disorder Newborn seizures Blood transfusion indication Sepsis

Design outcomes

Primary

Measure	Time frame
Bilirubin level. Timepoint: Day of hospitalization and during discharge. Method of measurement: Laboratory measurements in serum.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKorosh Kosari

Artesh University of Medical Sciences

koroshkosari@yahoo.com+98 21 7750 7512

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026